HB2693 Summary

• Prohibits insurance coverage (health, disability, and group disability policies) for genetic sequencing performed on devices produced by or substantially controlled by companies domiciled in foreign adversary countries including China, Russia, Iran, North Korea, Cuba, Venezuela, Syria, and Hong Kong Special Administrative Region.

• Requires health care institutions and research facilities to cease using genetic sequencers or software produced by foreign adversaries or their affiliates by December 31, 2026, with annual written compliance certification by institutional attorneys.

• Imposes $20,000 civil penalty per violation (defined as each instance of an individual's genome sequenced using prohibited technology) and allows affected patients or research subjects to recover statutory damages of at least $1,000 per instance.

• Mandates all genetic sequencing data be stored within the United States with reasonable encryption, access restrictions, and cybersecurity protections; prohibits remote data access without director approval.

• Provides whistleblower protections for employees and allows any individual to notify the Attorney General of violations.